Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

Investigators evaluated the risk for hepatocellular carcinoma after direct-acting antivirals (DAA)-cured hepatitis C virus (HCV) in DAA-naive adults with HIV-HCV coinfection and advanced fibrosis.

A 4-week multimodal prehabilitation program before ESD improves postoperative functional recovery, muscle strength, and mental QOL.

Olezarsen receives FDA Breakthrough Therapy status for adults with severe hypertriglyceridemia following positive results from CORE and CORE2 trials.

The FDA has approved Linzess (linaclotide) for treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older.

A manufacturing issue with Abbott FreeStyle Libre 3 sensors led to inaccurate readings, affecting about 3 million sensors worldwide.

The FDA approved perioperative durvalumab with FLOT chemotherapy for eligible patients with resectable Stage II-IVA gastric and GEJ cancers.

Intravenous anesthesia for painless gastroscopy among older adults is associated with lower postoperative cognitive dysfunction.

The San Francisco City Attorney filed a lawsuit targeting 10 major producers of ultraprocessed food for their negative health affects.

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

The World Health Organization's new strategic initiative focused on how to harness digital health technologies to improve health.